<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://safernicotine.wiki/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Diasmoke</id>
	<title>Diasmoke - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://safernicotine.wiki/mediawiki/index.php?action=history&amp;feed=atom&amp;title=Diasmoke"/>
	<link rel="alternate" type="text/html" href="https://safernicotine.wiki/mediawiki/index.php?title=Diasmoke&amp;action=history"/>
	<updated>2026-04-15T23:38:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://safernicotine.wiki/mediawiki/index.php?title=Diasmoke&amp;diff=24338&amp;oldid=prev</id>
		<title>CoEHAR: created a dedicated page for diasmoke project</title>
		<link rel="alternate" type="text/html" href="https://safernicotine.wiki/mediawiki/index.php?title=Diasmoke&amp;diff=24338&amp;oldid=prev"/>
		<updated>2022-10-31T15:29:17Z</updated>

		<summary type="html">&lt;p&gt;created a dedicated page for diasmoke project&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;[https://diasmoke.coehar.org DIASMOKE]&amp;#039;&amp;#039;&amp;#039; (Assessing the impact of combustion free-nicotine delivery technologies in Diabetic Smokers) &amp;#039;&amp;#039;&amp;#039;is an international, multicenter, open-label randomized controlled study designed to determine wheter T2DM cigarette smokers switching to CF-NDS experience measurable improvement in cardiovascular risk parameters as a consequence of avoiding exposure to cigarette smoke toxicants.&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
Little is known about the impact of the combustion-free nicotine delivery system on T2DM patients who smoke. &lt;br /&gt;
&lt;br /&gt;
This study aims to test the hypothesis that avoiding exposure to cigarette smoke toxicants may translate to measurable improvement in cardiovascular risk factors and functional parameters when type 2 diabetes mellitus (T2DM) patients who smoke switch to using C-F NDS compared with T2DM patients who continue to smoke conventional tobacco products.&lt;/div&gt;</summary>
		<author><name>CoEHAR</name></author>
	</entry>
</feed>